Objective: This case report will present bilateral synchronous percutaneous nephrolitholapaxy (PCNL) that was performed in Saiful Anwar General Hospital Malang for the first time. Case(s) Presentation: 49 years old male with flank pain on both sides continuously. Non contrast abdominal Computed Tomography (CT) scan showed bilateral pyelum stone and bilateral hydronephrosis. From blood analysis, the creatinine serum was 1.5 mg/dL and ureum serum was level 69.8 mg/dL. Discussion: Bilateral synchronous PCNL was performed in prone position, and stone fragmentation was done with pneumatic lithotripter, the operation last for about 2 hours with minimal amount of bleeding. After 3 months of follow-up, urology ultrasound and abdominal X-ray shows no residual stone, and normal ureum-creatinine level (0.77mg/dL; 43.7mg/dL). Conclusion: Bilateral synchronous PCNL is a safe choice to be done in order to treat bilateral pyelum stone, it can decrease length of stay , total cost therapy, and morbidity of the patient.
{"title":"EXPERIENCE OF BILATERAL SYNCHRONOUS PERCUTANEOUS NEPHROLITHOLAPAXY (PCNL)","authors":"Prasetyo Nugroho, P. Satyagraha, B. Daryanto","doi":"10.32421/juri.v30i2.850","DOIUrl":"https://doi.org/10.32421/juri.v30i2.850","url":null,"abstract":"Objective: This case report will present bilateral synchronous percutaneous nephrolitholapaxy (PCNL) that was performed in Saiful Anwar General Hospital Malang for the first time. Case(s) Presentation: 49 years old male with flank pain on both sides continuously. Non contrast abdominal Computed Tomography (CT) scan showed bilateral pyelum stone and bilateral hydronephrosis. From blood analysis, the creatinine serum was 1.5 mg/dL and ureum serum was level 69.8 mg/dL. Discussion: Bilateral synchronous PCNL was performed in prone position, and stone fragmentation was done with pneumatic lithotripter, the operation last for about 2 hours with minimal amount of bleeding. After 3 months of follow-up, urology ultrasound and abdominal X-ray shows no residual stone, and normal ureum-creatinine level (0.77mg/dL; 43.7mg/dL). Conclusion: Bilateral synchronous PCNL is a safe choice to be done in order to treat bilateral pyelum stone, it can decrease length of stay , total cost therapy, and morbidity of the patient.","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88875251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tanaya Ghinorawa, Gilang Samudera, Indrawarman Soeroharjo, A. Z. Hendri, Andy Zulfiqqar
Objective: This study aims to evaluate the association of the preoperative Neutrophil-lymphocyte ratio (NLR) and postoperative creatinine levels after kidney transplantation, which is a predictor factor for determining early postoperative transplantation complications. Material & Methods: We conducted a retrospective study of 33 patients enrolled in Sardjito General Hospital in Yogyakarta between 2017 and 2020. In this study, we observed the preoperative NLR and compared it with the postoperative creatinine level. The data were compared and analyzed. Results: This study showed that preoperative NLR in these 33 patients was 4.17 + 2.82. Postoperative creatinine levels were 2.38 + 1.75 mg/dL. Postoperative creatinine levels were higher in patients with low preoperative NLR (p=0.00). Besides, the correlation is weak and had a positive correlation direction (r=0.379). Conclusion: This study showed preoperative NLR and the postoperative serum creatinine level is correlated even weakly. NLR could be considered a predictor factor for determining postoperative transplantation complications, and even it still needs further research.
{"title":"A HIGH PREOPERATIVE NEUTROPHIL-LYMPHOCYTE RATIO AS AN INDICATOR OF EARLY RESPONSE OF KIDNEY TRANSPLANT","authors":"Tanaya Ghinorawa, Gilang Samudera, Indrawarman Soeroharjo, A. Z. Hendri, Andy Zulfiqqar","doi":"10.32421/juri.v30i2.833","DOIUrl":"https://doi.org/10.32421/juri.v30i2.833","url":null,"abstract":"Objective: This study aims to evaluate the association of the preoperative Neutrophil-lymphocyte ratio (NLR) and postoperative creatinine levels after kidney transplantation, which is a predictor factor for determining early postoperative transplantation complications. Material & Methods: We conducted a retrospective study of 33 patients enrolled in Sardjito General Hospital in Yogyakarta between 2017 and 2020. In this study, we observed the preoperative NLR and compared it with the postoperative creatinine level. The data were compared and analyzed. Results: This study showed that preoperative NLR in these 33 patients was 4.17 + 2.82. Postoperative creatinine levels were 2.38 + 1.75 mg/dL. Postoperative creatinine levels were higher in patients with low preoperative NLR (p=0.00). Besides, the correlation is weak and had a positive correlation direction (r=0.379). Conclusion: This study showed preoperative NLR and the postoperative serum creatinine level is correlated even weakly. NLR could be considered a predictor factor for determining postoperative transplantation complications, and even it still needs further research.","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85355179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zen Ary Prasetyo, Kurnia Penta Seputra, Rainy Umbas, Besut Daryanto
Objective: This study aimed to determine the management of early-stage testicular cancer among urologists in Indonesia by using a survey. Material & Methods: This research was a descriptive-analytic study using a survey method through a Google-forms questionnaire distributed to urologists throughout Indonesia who were willing to participate. Data were collected from September 1 to 30, 2021. Results: Of the total respondents, 15 (14.2%) respondents were consultant urologic oncologists, and 90 (85.71%) respondents were non-consultant urologists or consultant urologists non-oncology. There was no difference in the treatment given by consultant uro-oncologists and non-consultant urologists/consultant urologists non-oncology in the management of surveillance of stage IA-IB seminoma (66.7% vs. 55.6%, p-value = 0.207), chemotherapy of stage IIA-IIB seminoma (100.0% vs. 90.0%, p-value = 0.080), surveillance of stage I non-seminoma cancers (46.7% vs. 41.1%, p-value = 0.304), and chemotherapy of stage IIA and IIB non-seminoma cancers (80% vs. 91.1%, p-value = 0.193). Conclusion: In general, as many as 84.4% of oncology consultant urologists and 83.7% of non-consultant urologists/consultant urologists non-oncology have performed initial diagnostic examinations, treatment, and follow-up following testicular cancer management guidelines according to the European Association of Urology 2021.
目的:本研究旨在通过调查确定印度尼西亚泌尿科医生对早期睾丸癌的处理。材料与方法:本研究是一项描述性分析研究，采用调查方法，通过谷歌形式的问卷调查分发给印度尼西亚各地愿意参与的泌尿科医生。数据收集时间为2021年9月1日至30日。结果:泌尿外科肿瘤会诊医师15人(14.2%)，非泌尿外科会诊医师或非肿瘤科泌尿外科会诊医师90人(85.71%)。在IA-IB期精原细胞瘤的监测管理(66.7% vs. 55.6%， p值= 0.207)、IIA-IIB期精原细胞瘤的化疗(100.0% vs. 90.0%， p值= 0.080)、I期非精原细胞瘤的监测(46.7% vs. 41.1%， p值= 0.304)、IIA期和IIB期非精原细胞瘤的化疗(80% vs. 91.1%， p值= 0.193)方面，泌尿肿瘤科会诊医师和非肿瘤科泌尿科会诊医师/非肿瘤科会诊医师的治疗没有差异。结论:总体而言，根据欧洲泌尿外科协会2021年的数据，高达84.4%的肿瘤科会诊泌尿科医生和83.7%的非肿瘤科会诊泌尿科医生/非肿瘤科会诊泌尿科医生按照睾丸癌管理指南进行了初步诊断检查、治疗和随访。
{"title":"EARLY-STAGE TESTICULAR CANCER MANAGEMENT REFERRING TO EUROPEAN ASSOCIATION OF UROLOGY (EAU) GUIDELINES: A SURVEY IN INDONESIA","authors":"Zen Ary Prasetyo, Kurnia Penta Seputra, Rainy Umbas, Besut Daryanto","doi":"10.32421/juri.v30i2.842","DOIUrl":"https://doi.org/10.32421/juri.v30i2.842","url":null,"abstract":"Objective: This study aimed to determine the management of early-stage testicular cancer among urologists in Indonesia by using a survey. Material & Methods: This research was a descriptive-analytic study using a survey method through a Google-forms questionnaire distributed to urologists throughout Indonesia who were willing to participate. Data were collected from September 1 to 30, 2021. Results: Of the total respondents, 15 (14.2%) respondents were consultant urologic oncologists, and 90 (85.71%) respondents were non-consultant urologists or consultant urologists non-oncology. There was no difference in the treatment given by consultant uro-oncologists and non-consultant urologists/consultant urologists non-oncology in the management of surveillance of stage IA-IB seminoma (66.7% vs. 55.6%, p-value = 0.207), chemotherapy of stage IIA-IIB seminoma (100.0% vs. 90.0%, p-value = 0.080), surveillance of stage I non-seminoma cancers (46.7% vs. 41.1%, p-value = 0.304), and chemotherapy of stage IIA and IIB non-seminoma cancers (80% vs. 91.1%, p-value = 0.193). Conclusion: In general, as many as 84.4% of oncology consultant urologists and 83.7% of non-consultant urologists/consultant urologists non-oncology have performed initial diagnostic examinations, treatment, and follow-up following testicular cancer management guidelines according to the European Association of Urology 2021.","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"77 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91434349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study aims to research the characteristic of patients with urinary tract stones and the profiles of uric acid and cholesterol at the Kustati Islamic General Hospital (RSUI) in the period from October 2020 to March 2022. Material & Methods: This research uses the cross-sectional retrospective approach with the descriptive method. The research subjects are the patients with urinary tract stones that have undergone operations in Kustati Islamic General Hospital in the period between October 2020 and March 2022 as well as patients that have had their level of uric acid and cholesterol examined in the laboratory of Kustati Islamic General Hospital in the period from October 2020 to March 2022. Results: Urinary tract stones occur the most in men (70.3%) and in the age group 46-59 years old with a percentage nearing 50%. Urinary tract stones occur the most in the upper section of the urinary tract, mainly in the kidneys (67.2%). Hyperuricemia occur mostly in men while hypercholesterolemia occur mostly in women. Conclusion: The location of stone is mostly found in the kidneys. Patients with hyperuricemia are mostly men, while patients with hypercholesterolemia are mostly women.
{"title":"CHARACTERISTICS OF PATIENTS WITH URINARY TRACT STONES AND PROFILE OF URIC ACID AND CHOLESTEROL AT KUSTATI ISLAMIC GENERAL HOSPITAL SURAKARTA IN THE PERIOD OF OCTOBER 2020 TO MARCH 2022","authors":"Prasojo Muhamad, A. Utomo, T. Achmad","doi":"10.32421/juri.v30i2.873","DOIUrl":"https://doi.org/10.32421/juri.v30i2.873","url":null,"abstract":"Objective: This study aims to research the characteristic of patients with urinary tract stones and the profiles of uric acid and cholesterol at the Kustati Islamic General Hospital (RSUI) in the period from October 2020 to March 2022. Material & Methods: This research uses the cross-sectional retrospective approach with the descriptive method. The research subjects are the patients with urinary tract stones that have undergone operations in Kustati Islamic General Hospital in the period between October 2020 and March 2022 as well as patients that have had their level of uric acid and cholesterol examined in the laboratory of Kustati Islamic General Hospital in the period from October 2020 to March 2022. Results: Urinary tract stones occur the most in men (70.3%) and in the age group 46-59 years old with a percentage nearing 50%. Urinary tract stones occur the most in the upper section of the urinary tract, mainly in the kidneys (67.2%). Hyperuricemia occur mostly in men while hypercholesterolemia occur mostly in women. Conclusion: The location of stone is mostly found in the kidneys. Patients with hyperuricemia are mostly men, while patients with hypercholesterolemia are mostly women.","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89228759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rafael Otniel Kestito, A. S. Rahaju, Tarmono, A. Purba
Objective: This systematic review aims to compare IPSS score and Uroflowmetry (Qmax) results between Transurethral Resection of The Prostate (monopolar and bipolar TURP) and Transurethral Vaporization of The Prostate (PVP, ThuVARP, Biolitec, TUEVP, BPV). Material & Methods: Articles were obtained through online searches using Medline, Google Scholar, and Cochrane Library using keywords Transurethral Resection of The Prostate (TURP) dan Transurethral Vaporization of The Prostate (TUVP) and IPSS or Qmax. Results: A total of 6 RCTs and 3 Cohort consisted of 1212 BPH patients treated with TURP (B-TURP and B-TURP) or TUVP (TUVP, BPV, Biolitec, ThuVARP, GLVP(PVP)). There is a significant difference result of IPSS score and Qmax at the third month of follow-up after both therapies. Conclusion: The post-operative IPSS score and Qmax results at the third month of follow-up in BPH patients treated with TURP or TUVP presents varied results. TURP has a better post-operative IPSS score compared to Biolitec Laser, but not superior when compared with TUEVP, BPV, ThuVARP, and PVP. Notably, TURP has better post-operative Qmax results than BPV, TUEVP, and ThuVARP, but not when compared with PVP.
目的:本系统综述旨在比较经尿道前列腺切除术(单极和双极TURP)和经尿道前列腺汽化术(PVP, ThuVARP, Biolitec, TUEVP, BPV)的IPSS评分和尿流测定(Qmax)结果。材料与方法:通过Medline、谷歌Scholar和Cochrane Library等在线检索，检索关键词为经尿道前列腺切除术(Transurethral Resection of Prostate, TURP)、经尿道前列腺汽化(Transurethral Vaporization of The Prostate, TUVP)和IPSS或Qmax。结果:共有6项随机对照试验和3个队列，包括1212名接受TURP (B-TURP和B-TURP)或TUVP (TUVP, BPV, Biolitec, ThuVARP, GLVP(PVP))治疗的BPH患者。两种治疗后随访第3个月IPSS评分和Qmax结果差异有统计学意义。结论:经TURP或TUVP治疗的BPH患者，随访第3个月IPSS评分和Qmax结果存在差异。与Biolitec Laser相比，TURP的术后IPSS评分更高，但与TUEVP、BPV、ThuVARP和PVP相比并不优越。值得注意的是，TURP的术后Qmax结果优于BPV、TUEVP和ThuVARP，但与PVP相比则不同。
{"title":"OUTCOMES ANALYSIS OF TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) AND TRANSURETHRAL VAPORIZATION OF THE PROSTATE (TUVP) IN PATIENT WITH BENIGN PROSTATE HYPERPLASIA: SYSTEMATIC REVIEW","authors":"Rafael Otniel Kestito, A. S. Rahaju, Tarmono, A. Purba","doi":"10.32421/juri.v30i2.845","DOIUrl":"https://doi.org/10.32421/juri.v30i2.845","url":null,"abstract":"Objective: This systematic review aims to compare IPSS score and Uroflowmetry (Qmax) results between Transurethral Resection of The Prostate (monopolar and bipolar TURP) and Transurethral Vaporization of The Prostate (PVP, ThuVARP, Biolitec, TUEVP, BPV). Material & Methods: Articles were obtained through online searches using Medline, Google Scholar, and Cochrane Library using keywords Transurethral Resection of The Prostate (TURP) dan Transurethral Vaporization of The Prostate (TUVP) and IPSS or Qmax. Results: A total of 6 RCTs and 3 Cohort consisted of 1212 BPH patients treated with TURP (B-TURP and B-TURP) or TUVP (TUVP, BPV, Biolitec, ThuVARP, GLVP(PVP)). There is a significant difference result of IPSS score and Qmax at the third month of follow-up after both therapies. Conclusion: The post-operative IPSS score and Qmax results at the third month of follow-up in BPH patients treated with TURP or TUVP presents varied results. TURP has a better post-operative IPSS score compared to Biolitec Laser, but not superior when compared with TUEVP, BPV, ThuVARP, and PVP. Notably, TURP has better post-operative Qmax results than BPV, TUEVP, and ThuVARP, but not when compared with PVP. \u0000 ","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76313834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study aims to identify and evaluate the impact of COVID-19 on urological interventions at Soetomo general-academic hospital as the tertiary referral center. Material & Methods: This study is a descriptive-retrospective, single-center study that included all confirmed cases of COVID-19 in urological patients from March 1, 2020 until December 31, 2021 at Soetomo general-academic hospital. We investigated these patients' characteristics, focusing on the demography, clinical data, and eventual outcome. Patient's gender, age, primary urological presentation, COVID-19-related symptom, comorbidity, chest x-ray result, and laboratory value were among the involved variables. The patient's outcome was categorized into death, delayed intervention, or intervention as scheduled. Results: Seventy-seven patients were enrolled, with a mean age of 44.2 years. Fever was found in 42 (54%) patients and respiratory symptoms in 32 (41.5%) patients. An NLR value of >6 was found in 55.8% of patients. A total of 18 patients experienced LUTS (23.4%), 33 patients presented with hematuria (42.9%), and 30 patients had urinary tract infections (39%). Nineteen out of 77 patients (27.3%) died before intervention. On the other hand, surgical intervention in 37 (66%) patients were delayed due to self-isolation, while intervention in 19 (34%) patients was performed as scheduled due to their emergency nature. Conclusion: Urological patients infected with COVID-19 were impacted by the delay of surgical procedures and mortality in the first 22 months of the pandemic.
{"title":"IMPACT OF COVID – 19 ON UROLOGICAL INTERVENTIONS AT TERTIARY REFERRAL HOSPITAL","authors":"L. Subihardi, J. Renaldo, M. Soebadi","doi":"10.32421/juri.v30i2.838","DOIUrl":"https://doi.org/10.32421/juri.v30i2.838","url":null,"abstract":"Objective: This study aims to identify and evaluate the impact of COVID-19 on urological interventions at Soetomo general-academic hospital as the tertiary referral center. Material & Methods: This study is a descriptive-retrospective, single-center study that included all confirmed cases of COVID-19 in urological patients from March 1, 2020 until December 31, 2021 at Soetomo general-academic hospital. We investigated these patients' characteristics, focusing on the demography, clinical data, and eventual outcome. Patient's gender, age, primary urological presentation, COVID-19-related symptom, comorbidity, chest x-ray result, and laboratory value were among the involved variables. The patient's outcome was categorized into death, delayed intervention, or intervention as scheduled. Results: Seventy-seven patients were enrolled, with a mean age of 44.2 years. Fever was found in 42 (54%) patients and respiratory symptoms in 32 (41.5%) patients. An NLR value of >6 was found in 55.8% of patients. A total of 18 patients experienced LUTS (23.4%), 33 patients presented with hematuria (42.9%), and 30 patients had urinary tract infections (39%). Nineteen out of 77 patients (27.3%) died before intervention. On the other hand, surgical intervention in 37 (66%) patients were delayed due to self-isolation, while intervention in 19 (34%) patients was performed as scheduled due to their emergency nature. Conclusion: Urological patients infected with COVID-19 were impacted by the delay of surgical procedures and mortality in the first 22 months of the pandemic. \u0000 ","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88575052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anissa Ismiyanti, R. Fauzan, Ardiansyah Periadi, Hendra Herman, W. Rachman, Herlambang, H. Dewi
Objective: This study aims to determine the relationship between Lower Urinary Tract Symptoms (LUTS) in patients with Benign Prostatic Hyperplasia (BPH) and erectile dysfunction at Raden Mattaher Hospital Jambi. Material & Methods: This research is an observational analytic with a cross sectional approach. The sample of this study includes 48 people using total sampling technique. Data analysis was carried out to test the hypothesis by the Spearman correlation test. Results: Based on the results of the Spearman correlation test analysis showed that there was a statistically significant relation (p=0.000) between Lower Urinary Tract Symptoms (LUTS) in patients with Benign Prostatic Hyperplasia (BPH) and erectile dysfunction. Conclusion: There is a significant relation between Lower Urinary Tract Symptoms (LUTS) in patients with Benign Prostatic Hyperplasia (BPH) and erectile dysfunction at Raden Mattaher Hospital Jambi.
目的:本研究旨在确定Raden Mattaher医院Jambi的良性前列腺增生(BPH)患者下尿路症状(LUTS)与勃起功能障碍之间的关系。材料与方法:本研究采用横断面方法进行观察分析。本研究的样本包括48人，采用全抽样技术。数据分析采用Spearman相关检验对假设进行检验。结果:Spearman相关检验分析结果显示，良性前列腺增生(BPH)患者的下尿路症状(LUTS)与勃起功能障碍之间有统计学意义(p=0.000)。结论:在Jambi Raden Mattaher医院，良性前列腺增生(BPH)患者的下尿路症状(LUTS)与勃起功能障碍有显著关系。
{"title":"THE CORRELATION OF LOWER URINARY TRACT SYMPTOMS (LUTS) ON BENIGN PROSTATIC HYPERPLASIA (BPH) PATIENTS AND ERECTILE DYSFUNCTION IN RADEN MATTAHER HOSPITAL JAMBI","authors":"Anissa Ismiyanti, R. Fauzan, Ardiansyah Periadi, Hendra Herman, W. Rachman, Herlambang, H. Dewi","doi":"10.32421/juri.v30i2.793","DOIUrl":"https://doi.org/10.32421/juri.v30i2.793","url":null,"abstract":"Objective: This study aims to determine the relationship between Lower Urinary Tract Symptoms (LUTS) in patients with Benign Prostatic Hyperplasia (BPH) and erectile dysfunction at Raden Mattaher Hospital Jambi. Material & Methods: This research is an observational analytic with a cross sectional approach. The sample of this study includes 48 people using total sampling technique. Data analysis was carried out to test the hypothesis by the Spearman correlation test. Results: Based on the results of the Spearman correlation test analysis showed that there was a statistically significant relation (p=0.000) between Lower Urinary Tract Symptoms (LUTS) in patients with Benign Prostatic Hyperplasia (BPH) and erectile dysfunction. Conclusion: There is a significant relation between Lower Urinary Tract Symptoms (LUTS) in patients with Benign Prostatic Hyperplasia (BPH) and erectile dysfunction at Raden Mattaher Hospital Jambi.","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74249699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study aims to determine the response of penis growth to testosterone injection. Material & Methods: The study was conducted on all cases of micropenis from January 2016 to December 2020. Each subject who met the criteria for micropenis received 25 mg of intramuscular testosterone ester injection, in 4 doses with an interval of 1 week. Evaluation is done at the beginning, before administration of testosterone, then an evaluation is carried out for each patient before testosterone injection until 1 week after the 4th injection. Penis measurement is done by fully stretched length measurement. Results: There were 62 patients who met the criteria for micropenis. The average age of patients with micropenis when they first came was 5.9 years. The patient's mean initial penile length was 2.13 cm. There was an increase in penis length of 32% in the first injection, 28% after the second injection, 18% after the third injection and 14% after the fourth injection. The average length of the penis at the first, second, third and fourth injections was 2.53 cm, 3.24 cm, 3.65 cm and 4.01 cm, respectively. At the end of treatment, there was an average increase in penile length of 75.8% compared to the beginning of treatment. Conclusion: In conclusion, it can be said that testosterone therapy in micropenis patients gave a good response in terms of increasing penile length by 75.8% and increasing the average from 2.13 cm to 4.01 cm.
{"title":"PENIS GROWTH RESPONSE TO HORMONAL THERAPY IN CHILDREN WITH MICROPENIS AT HASAN SADIKIN HOSPITAL","authors":"Evan Gandakusuma, Jupiter Sibarani","doi":"10.32421/juri.v30i2.776","DOIUrl":"https://doi.org/10.32421/juri.v30i2.776","url":null,"abstract":"Objective: This study aims to determine the response of penis growth to testosterone injection. Material & Methods: The study was conducted on all cases of micropenis from January 2016 to December 2020. Each subject who met the criteria for micropenis received 25 mg of intramuscular testosterone ester injection, in 4 doses with an interval of 1 week. Evaluation is done at the beginning, before administration of testosterone, then an evaluation is carried out for each patient before testosterone injection until 1 week after the 4th injection. Penis measurement is done by fully stretched length measurement. Results: There were 62 patients who met the criteria for micropenis. The average age of patients with micropenis when they first came was 5.9 years. The patient's mean initial penile length was 2.13 cm. There was an increase in penis length of 32% in the first injection, 28% after the second injection, 18% after the third injection and 14% after the fourth injection. The average length of the penis at the first, second, third and fourth injections was 2.53 cm, 3.24 cm, 3.65 cm and 4.01 cm, respectively. At the end of treatment, there was an average increase in penile length of 75.8% compared to the beginning of treatment. Conclusion: In conclusion, it can be said that testosterone therapy in micropenis patients gave a good response in terms of increasing penile length by 75.8% and increasing the average from 2.13 cm to 4.01 cm.","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"731 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78759141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study was aimed to know the complication and safety of TPPB-VY in clinical practice. Material & Methods: TPPB were performed in 34 patients between January 2019 and Juni 2021. Ethical approval of this study was sought from the hospital authorities (IRB number: LB.02.01/X.6.5/ 55/2020). Patients underwent systematic 10-12 core TPPB depend on the prostate volume with intravenous light sedation. The patient was included to the study if PSA ≥ 4 ng/ml and/or Digital Rectal Examination (DRE) results suggestive of prostate cancer. Procedures were performed without any antibiotic prophylaxis or an enema before the procedure and post procedure the patients just get an oral fluoroquinolones and low potent analgetics (if needed). The complication include pain level post procedure (using VAS), perineal hematoma, fever and retention post biopsy were recorded. Results: In all, 34 patients were included in the study. The result showed that perineal pain perceived by patients post procedure were 76.47% (26 out of 34 patients) but the VAS score just mild around 0-2. There were 23.53% (8 out of 34 patients) hematuria, 5.88% (2 out of 34 patients) acute urinary retention and 2.9 % (1 out of 34 patients) perineal hematoma. No fever or clinical infection was observed and 82.35% (28 out of 34 patients) patients presented with minor complications (ClavienDindo I). Only one of the patients were hospitalized due to the post-biopsy complication that need intervention. Conclusion: This is the first study TPPB using Novel Affordable VY probe. The results show clinically insignificant complication without infection. TPPB using Novel Affordable VY probe is feasible and safe.
{"title":"COMPLICATION AND SAFETY OF TRANSPERINEAL PROSTATE BIOPSY USING NOVEL AFFORDABLE VY PROBE (TPPB-VY) IN CLINICAL PRACTICE : A PILOT STUDY","authors":"Ali Ridho Al Haddar, S. Pramod, Ferry Safriadi","doi":"10.32421/juri.v30i2.781","DOIUrl":"https://doi.org/10.32421/juri.v30i2.781","url":null,"abstract":"Objective: This study was aimed to know the complication and safety of TPPB-VY in clinical practice. Material & Methods: TPPB were performed in 34 patients between January 2019 and Juni 2021. Ethical approval of this study was sought from the hospital authorities (IRB number: LB.02.01/X.6.5/ 55/2020). Patients underwent systematic 10-12 core TPPB depend on the prostate volume with intravenous light sedation. The patient was included to the study if PSA ≥ 4 ng/ml and/or Digital Rectal Examination (DRE) results suggestive of prostate cancer. Procedures were performed without any antibiotic prophylaxis or an enema before the procedure and post procedure the patients just get an oral fluoroquinolones and low potent analgetics (if needed). The complication include pain level post procedure (using VAS), perineal hematoma, fever and retention post biopsy were recorded. Results: In all, 34 patients were included in the study. The result showed that perineal pain perceived by patients post procedure were 76.47% (26 out of 34 patients) but the VAS score just mild around 0-2. There were 23.53% (8 out of 34 patients) hematuria, 5.88% (2 out of 34 patients) acute urinary retention and 2.9 % (1 out of 34 patients) perineal hematoma. No fever or clinical infection was observed and 82.35% (28 out of 34 patients) patients presented with minor complications (ClavienDindo I). Only one of the patients were hospitalized due to the post-biopsy complication that need intervention. Conclusion: This is the first study TPPB using Novel Affordable VY probe. The results show clinically insignificant complication without infection. TPPB using Novel Affordable VY probe is feasible and safe.","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91098559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study aims to report a case of bladder embryonal rhabdomyosarcoma in an 18-months-old boy. Case(s) Presentation: An 18-months-old boy presented with complaint of difficult urinating since the last 2 months before presentation. It was accompanied with hematuria, blood clot and palpable mass in the lower abdomen. Magnetic resonance imaging (MRI) of lower abdomen showed a solid mass in the inferior bladder wall, involved bilateral ureterovesical junction (UVJ) that caused bilateral severe hydroureteronephrosis, lymphadenopathy, and multiple nodul in both lungs. Cystoscopy was performed and found intrabladder tumor near the bladder neck and trigonum. Then biopsy of the bladder tumor was performed. Pathology result of the specimens showed bladder embryonal rhabdomyosarcoma. Then immunohistochemistry examination was performed with desmin and myogenin antibody to confirm bladder embryonal rhabdomyosarcoma diagnosis. Discussion: Bladder embryonal rhabdomyosarcoma often involves the bladder neck and trigone. In general, clinical symptoms relate to mass and blockage caused by mass. Ultrasound is the first imaging examination performed. Magnetic resonance imaging (MRI) helps depict the mass, usually hyperintense on the T2 image. The immunohistochemical examination is an important examination of skeletal muscle markers. Desmin found in muscle is used to diagnose rhabdomyosarcoma. Conclusion: Bladder embryonal rhabdomyosarcoma is a diagnostic challenge as it is a rare malignant tumor. The clinician needs to be aware of this entity and performed immunohistochemistry as an important examination to accurately diagnose embryonal rhabdomyosarcoma of the bladder. Keywords: Bladder, immunohistochemistry, rhabdomyosarcoma.
{"title":"BLADDER EMBRYONAL RHABDOMYOSARCOMA IN AN 18-MONTHS-OLD BOY: A CASE REPORT","authors":"I. M. Mahandita, B. Daryanto, Pradana Nurhadi","doi":"10.32421/juri.v30i1.830","DOIUrl":"https://doi.org/10.32421/juri.v30i1.830","url":null,"abstract":"Objective: This study aims to report a case of bladder embryonal rhabdomyosarcoma in an 18-months-old boy. Case(s) Presentation: An 18-months-old boy presented with complaint of difficult urinating since the last 2 months before presentation. It was accompanied with hematuria, blood clot and palpable mass in the lower abdomen. Magnetic resonance imaging (MRI) of lower abdomen showed a solid mass in the inferior bladder wall, involved bilateral ureterovesical junction (UVJ) that caused bilateral severe hydroureteronephrosis, lymphadenopathy, and multiple nodul in both lungs. Cystoscopy was performed and found intrabladder tumor near the bladder neck and trigonum. Then biopsy of the bladder tumor was performed. Pathology result of the specimens showed bladder embryonal rhabdomyosarcoma. Then immunohistochemistry examination was performed with desmin and myogenin antibody to confirm bladder embryonal rhabdomyosarcoma diagnosis. Discussion: Bladder embryonal rhabdomyosarcoma often involves the bladder neck and trigone. In general, clinical symptoms relate to mass and blockage caused by mass. Ultrasound is the first imaging examination performed. Magnetic resonance imaging (MRI) helps depict the mass, usually hyperintense on the T2 image. The immunohistochemical examination is an important examination of skeletal muscle markers. Desmin found in muscle is used to diagnose rhabdomyosarcoma. Conclusion: Bladder embryonal rhabdomyosarcoma is a diagnostic challenge as it is a rare malignant tumor. The clinician needs to be aware of this entity and performed immunohistochemistry as an important examination to accurately diagnose embryonal rhabdomyosarcoma of the bladder. \u0000Keywords: Bladder, immunohistochemistry, rhabdomyosarcoma.","PeriodicalId":13565,"journal":{"name":"Indonesian Journal of Urology","volume":"61 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81452239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：